GB859394A - Process for preparing substituted tetracyclines - Google Patents

Process for preparing substituted tetracyclines

Info

Publication number
GB859394A
GB859394A GB25420/58A GB2542058A GB859394A GB 859394 A GB859394 A GB 859394A GB 25420/58 A GB25420/58 A GB 25420/58A GB 2542058 A GB2542058 A GB 2542058A GB 859394 A GB859394 A GB 859394A
Authority
GB
United Kingdom
Prior art keywords
tetracycline
morpholinomethyl
hydrogen
acid
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB25420/58A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of GB859394A publication Critical patent/GB859394A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/40Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44Naphthacenes; Hydrogenated naphthacenes
    • C07C2603/461,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Substituted-N1- (primary or secondary aminomethyl) tetracyclines are prepared by reacting a compound of formula: <FORM:0859394/IV(b)/1> where TC represents all except the carboxamido group of tetracycline, oxytetracycline, chlortetracycline or bromtetracycline, and B is a primary or secondary amino group with at least one equivalent of a hydrogen replacing agent whereby an active hydrogen located on a carbon atom in a phenolic ring or on an oxygen atom is replaced. The hydrogen replacing agent is an acid halide, acid anhydride, alkyl haloformate, aralkyl haloformate, phosgene, an epoxide, beta propiolactone, dihydropyran, an olefine, a halogen, a phosphorous halide, halosulphuric acid, iodoacetic acid, a diazonium salt, an isocyanate, nitrous acid, nitric acid, sulphuryl chloride, a diazoalkane, a tertiary alcohol boron trifluoride complex, a sulphur tri-oxide dialkylamine complex, an alkyl orthoformate, phenyllithium and carbon dioxide in sequence, and mercuric acetate and sulphur dichloride. Radical B may be a secondary amino group consisting of di (lower) alkylamino, pyrrolidino, piperidino, morpholino, 2, 6-dimethyl-morpholino, N1-(lower) alkyl piperazino, pipecolino or dibenzylamino. Reactions take place at -40 to 50 DEG C. in anhydrous solvents such as pyridine, glacial acetic acid, ethyl carbamate, N, N-dimethyl acetamide, N-methyl-2- pyrrolidone, 1, 2-dimethoxyethane, N, N-di methyl formamide, diethylene glycol dimethyl ether, formamide and dimethyl sulphoxide. The substituted -N1- (primary or secondary aminomethyl) tetracycline is reduced to the corresponding substituted tetracycline by (a) catalytic reduction by hydrogen in a solvent such as methanol or (b) reduction by means of aqueous solution of a bisulphite especially sodium bisulphite. Examples describe the preparation of (a) 3-nitrophthalyl -N1- (morpholino-methyl) tetracycline from N1-morpholinomethyl) tetracycline and 3-nitrophthalic anhydride (b) monobenzoyl-N1-(dibenzylamino methyl) tetracycline from N1-(dibenzylaminomethyl) tetracycline and benzoyl chloride (c) p-nitrobenzoyl-N1-(morpholinomethyl) tetracycline using p-nitrobenzoyl chloride and N1-(morpholinomethyl) tetracycline (d) p-toluenesulphonyl-N- (morpholinomethyl) tetracycline using p-toluenesulphonyl-chloride and N1-(morpholinomethyl) tetracycline; (e) p-toluenesulphonyltetracycline by reducing (d) with hydrogen in presence of Raney Nickel catalyst; (f) monobenzoyl-N-1 (morpholinomethyl) tetracycline using benzoyl chloride and N1-(morpholinomethyl) tetracycline; (g) monobenzoyl tetracycline by reducing (b) with catalytic hydrogen or aqueous sodium bisulphite (h) o-carbethoxy-N1 (morpholinomethyl) tetracycline using N1 (morpholinomethyl) tetracycline and ethyl chloro formate; (i) o-carbethoxy-N1-(morpholinomethyl) tetracycline by reducing (j) with catalytic hydrogen or aqueous sodium bisulphite; (k) p-nitrobenzoyl tetracycline by reducing (c) with catalytic hydrogen (d) monobenzoyl -N1- (dibenzylaminomethyl) tetracycline using benzoyl chloride and N1-(dibenzylaminomethyl) tetracycline (m) p-nitrophenylazo-N1-morphilinomethyl tetracycline hydroacetate <FORM:0859394/IV(b)/2> from diazotised p-nitroaniline and N1-morpholinomethyl tetracycline followed by treatment with acetic acid (n) p-nitrophenylazo-N1-pyrrolidino methyl tetracycline dihydroacetate as in (m) using N1-(pyrrolidino methyl) tetracycline. Salts may be formed with hydrochloric, sulphuric, sulphonic, tartaric, hydrobromic, hydriodic, glycollic, citric, acetic and other fatty acids. The compounds may be used as a general disinfectant and veterinary medicine (see Group VI) or a preservative of fish. Specification 809,585 is referred to.ALSO:A veterinary preparation in the form of a capsule or suspension in a vegetable oil contains a substituted -N 1- (primary-or secondary-aminomethyl) tetracycline prepared by reacting a compound of formula: <FORM:0859394/VI/1> where TC represents all except the carboxamido group of tetracycline, oxytetracycline, chlortetracycline or bromtetracycline and B represents a primary or secondary amino group, with at least one equivalent of a hydrogen replacing reagent wherein an active hydrogen located on a carbon atom in a phenolic ring or on an oxygen atom is replaced (see Group IV (b)). The tetracycline may be in the form of the hydrochloride, sulphate, sulphamate, tartrate, hydrobromate, hydriodate, glycollate, citrate, maleate, phosphate, succinate or acetate. Aqueous solutions or suspensions may be used as general disinfectants. The compounds may be used for the preservation of fish at the rate of 0,1 to 1,000 mgm/kg of weight of the fish. They are used in solution or suspension in a liquid e.g. water or as a powder with a diluent such as talc. Specification 809,585 is referred to.
GB25420/58A 1957-08-08 1958-08-07 Process for preparing substituted tetracyclines Expired GB859394A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US859394XA 1957-08-08 1957-08-08

Publications (1)

Publication Number Publication Date
GB859394A true GB859394A (en) 1961-01-25

Family

ID=22194977

Family Applications (1)

Application Number Title Priority Date Filing Date
GB25420/58A Expired GB859394A (en) 1957-08-08 1958-08-07 Process for preparing substituted tetracyclines

Country Status (1)

Country Link
GB (1) GB859394A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3137627A (en) * 1962-03-12 1964-06-16 Bristol Myers Co Nu-(1-pyrrolidinomethyl) tetracycline and acid compositions for aqueous acidified injections having a ph of not more than about 4

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3137627A (en) * 1962-03-12 1964-06-16 Bristol Myers Co Nu-(1-pyrrolidinomethyl) tetracycline and acid compositions for aqueous acidified injections having a ph of not more than about 4

Similar Documents

Publication Publication Date Title
GB825311A (en) Photographic silver halide emulsions and photographic developers containing colour couplers and method of producing coloured photographic images
US2722529A (en) Amides of certain l-amevoalkyl-x-phenyl
GB859394A (en) Process for preparing substituted tetracyclines
GB640492A (en) Improvements in or relating to methods of preparing aminoketones or their reduction products or salts thereof
Doak A modified Bart reaction
GB1011850A (en) Sulphonamides and a process for the manufacture thereof
CA1304369C (en) Azoniaspironortropanol esters and processes for the preparation thereof
GB1374820A (en) Substituted dioxypiperidines and a process for the preparation thereof
GB808073A (en) Manufacture of new sulphonyl-ureas
GB951461A (en) Improvements in or relating to substituted 2-phenoxy-cyclopropylamines
GB777380A (en) New salts of penicillin with alkylene diamines and processes of making them
GB706409A (en) Process for the preparation of diethylaminoaceto-2m-xylidide
GB842925A (en) Orally-effective antidiabetic compounds
GB899556A (en) Substituted isonicotinic acid amides and process for their manufacture
GB1280942A (en) New basically substituted 1,2,3-benzotriazine-4(3h)-one derivatives and processes for the production thereof
US2721192A (en) Aminoalkyl-isobornyl ether salts of penicillin
GB485377A (en) Improvements in the manufacture and production of aminoketones
GB921979A (en) Substituted 2:3-diphenyl-propylamines and process for their manufacture
GB852422A (en) New urea derivatives and process for their manufacture
GB925988A (en) Improvements in and relating to quaternary ammonium compounds and the preparation thereof
GB839797A (en) Substituted thioureas and their use as pesticidal agents
GB509804A (en) Process for the manufacture of sulphinic acid derivatives
GB793063A (en) New nitrosopyrazoles and fungicidal compositions containing them
GB831185A (en) Cyclo-octylamine derivatives and their production
GB801394A (en) 1:3:4-thiadiazoles and their preparation